Cargando…
Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors
BACKGROUND: Linaclotide has been proposed as a treatment for the same gastrointestinal indications for which lubiprostone has been approved, chronic idiopathic constipation and irritable bowel syndrome with constipation. Stressors damage the epithelial cell barrier and cellular homeostasis leading t...
Autores principales: | Cuppoletti, John, Blikslager, Anthony T, Chakrabarti, Jayati, Nighot, Prashant K, Malinowska, Danuta H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403872/ https://www.ncbi.nlm.nih.gov/pubmed/22553939 http://dx.doi.org/10.1186/1471-2210-12-3 |
Ejemplares similares
-
Methadone but not Morphine Inhibits Lubiprostone-Stimulated Cl(−) Currents in T84 Intestinal Cells and Recombinant Human ClC-2, but not CFTR Cl(−) Currents
por: Cuppoletti, John, et al.
Publicado: (2012) -
Genetic Ablation of the ClC-2 Cl- Channel Disrupts Mouse Gastric Parietal Cell Acid Secretion
por: Nighot, Meghali P., et al.
Publicado: (2015) -
A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa
por: Kang, Sang Bum, et al.
Publicado: (2015) -
Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
por: Nag, Arpita, et al.
Publicado: (2020) -
Improving the Gastrointestinal
Stability of Linaclotide
por: Braga Emidio, Nayara, et al.
Publicado: (2021)